Fadal R G
Otolaryngol Clin North Am. 1985 Nov;18(4):805-19.
A great deal of the immunotherapy failures are preventable if certain criteria are met and guidelines followed. It is mandatory that immunotherapy only be used for those conditions known to be atopic IgE-mediated diseases. With an IgE mechanism established as a foundation for immunotherapy, adherence to certain guidelines (Table 9) will ensure an optimal response to specific therapy. Experience in recent years with in vitro allergy (Table 10) testing in conjunction with or as a replacement for skin testing has resulted in greater efforts as discontinuing immunotherapy previously placed on this treatment, for whom the original diagnosis of allergy cannot be confirmed based on stringent criteria for identifying an IgE-dependent genesis. Too many patients are treated by immunotherapy on the basis of minimal reactions to skin testing or of coincidentally positive skin tests unrelated to the etiology of the patient's complaints.
如果满足某些标准并遵循指南,许多免疫疗法失败是可以预防的。免疫疗法仅用于已知为特应性IgE介导疾病的情况,这是强制性的。以IgE机制作为免疫疗法的基础,遵循某些指南(表9)将确保对特异性治疗有最佳反应。近年来,结合或替代皮肤试验进行体外过敏试验(表10)的经验,使得人们更加努力地停止对那些根据严格的IgE依赖性发病诊断标准无法确诊过敏的患者进行免疫疗法。太多患者基于对皮肤试验的轻微反应或与患者主诉病因无关的偶然阳性皮肤试验而接受免疫疗法治疗。